Sygnis Pharma
SYGNIS Pharma AG, a specialty pharmaceutical company, engages in the research, development, and marketing of drugs for the treatment of.
Launch date
Employees
Company register number HRB 335706 (Mannheim)
Heidelberg Baden-Württemberg (HQ)
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|---|---|
Revenues | <1m | 2.0m | 8.0m | <1m | <1m | <1m |
% growth | - | 229 % | 300 % | (98 %) | 27 % | (66 %) |
EBITDA | (3.5m) | - | - | - | (2.0m) | 60.0m |
% EBITDA margin | (579 %) | - | - | - | (995 %) | 86957 % |
Profit | (4.0m) | - | - | - | - | - |
% profit margin | (661 %) | - | - | - | - | - |
EV / revenue | 64.7x | - | - | - | - | - |
EV / EBITDA | -11.2x | - | - | - | - | - |
R&D budget | 1.9m | - | - | - | - | - |
R&D % of revenue | 309 % | - | - | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | N/A | IPO | |
Total Funding | - |
Recent News about Sygnis Pharma
EditInvestments by Sygnis Pharma
EditACQUISITION by Sygnis Pharma Jun 2008
ACQUISITION by Sygnis Pharma Dec 2016
ACQUISITION by Sygnis Pharma Jun 2017